Recent Updates
Recently added Catalysts
BAX Positive Sentiment

Baxter Reports Second-Quarter 2026 Results

Thursday, July 30, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Baxter International Inc. reported strong second-quarter results for 2026, surpassing expectations on both revenue and profit. The company's performance was bolstered by solid operating results and an unanticipated tariff refund. CEO Andrew Hider expressed optimism about the company's ongoing progress and core operating momentum.
Price reaction · baseline $24.77 (2026-07-29 close) · hit pre-market · 1 other BAX headline(s) in the window, move may be shared
day 0 close
+8%
day 1
+5.6%
day 3
+14.5%

Market Sentiment Analysis

POSITIVE FACTORS

  • Second-quarter results exceeded expectations.
  • Strong operating performance contributed to growth.
  • Benefit from an unexpected tariff refund.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+71%
120-day peak, hindsight
Typical move
2.1%
average across 13 past catalysts
Lead asset
Glycerophosphate
Phase 1 · Parenteral Nutrition

Full Press Release Details

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the second quarter of 2026. “Our second-quarter results exceeded expectations on both the top and bottom lines, driven by both operating performance and an additional benefit from a tariff refund that was not previously contemplated in our guidance,” said Andrew Hider, president and CEO. “While we’re encouraged by this steady progress and core operating momentum, we remain

Frequently Asked Questions

What were Baxter's Q2 2026 results?

Baxter's Q2 2026 results exceeded expectations in both revenue and profit.

What contributed to Baxter's strong performance?

The strong performance was driven by solid operating results and a tariff refund.

Who is the CEO of Baxter?

Andrew Hider is the president and CEO of Baxter International.

What is the significance of the tariff refund?

The tariff refund provided an additional benefit that was not anticipated in guidance.

ShareAdd on Google
Tags: BAX Baxter International Q2 2026 tariff refund financial results
Last updated: Jul 30, 2026

Biotech snapshot

Cash runway
$2150M liquidity · $0M/mo burn
Low dilution risk
Lead asset
GlycerophosphatePhase 1
Parenteral Nutrition →

Catalyst track record

+71%
best trade around BAX's most recent catalyst

Peak hindsight return over a 120-day window, across 13 tracked FDA/PDUFA catalysts for BAX.

See every catalyst's timing & PoA →